The CMS is postponing finalization of a proposed rule that would require hospitals to publish insurer-negotiated rates for health care services, and Administrator Seema Verma indicated in a tweet that the rule will be released along with a comprehensive proposal for health plan transparency. The agency said it received over 1,400 comments on the proposal.
A spokesman for Sen. John Cornyn, R-Texas, said he plans to try again next week to obtain unanimous consent on legislation that would restrict efforts by drugmakers to delay competition from generic drugs. Sens. Chuck Grassley, R-Iowa, and Dick Durbin, D-Ill., also failed in their attempt to pass by unanimous consent a measure that would require drug companies to disclose prices in television ads.
The FDA is seeking public comment on its draft version of best practices for postmarket safety surveillance of drugs and biologics. The draft discusses surveillance for different product types, as well as specific patient populations, identification of safety signals and possible agency actions.
The US government has filed a lawsuit against Gilead Sciences for allegedly infringing government-owned patents related to the company's HIV drug Truvada. Gilead donated Truvada to the government for testing purposes, and the CDC determined it could be used to prevent infection. It has received several patents for treatment regimens it developed using Truvada.
Pharmacy benefit managers negotiate with drugmakers to obtain the best possible prices for patients, taxpayers and employers and pass along savings to health insurance plans so they can keep premiums and copays low, writes PCMA CEO JC Scott. Moreover, PBMs provide innovative tools that improve patient care and health, Scott writes.
Certain provisions in legislation bound for New York Gov. Andrew Cuomo's desk would be "counterproductive to the state's efforts to rein in health care costs and should be removed from the potential law," writes Heather Briccetti, president and CEO of the Business Council of New York.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 270 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications